BRWA
AUTL

B. Riley Wealth Advisors’s Autolus Therapeutics AUTL Stock Holding History

B. Riley Wealth Advisors’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,000
Closed -$39.6K – 1397
2024
Q1 		$39.6K Buy
+17,000
New +$106K ﹤0.01% 1407
2023
Q4 		– Sell
-17,000
Closed -$39.6K – 1396
2023
Q3 		$39.6K Sell
17,000
-5,000
-23% -$14.2K ﹤0.01% 1407
2023
Q2 		$52.4K Buy
+22,000
New +$52.2K ﹤0.01% 1481

Other funds holding AUTL

SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

B. Riley Wealth Advisors's AUTL Position: Q2 2024 in Review

B. Riley Wealth Advisors sold out of Autolus Therapeutics (AUTL) in Q2 2024, closing a stake of 17,000 shares — an estimated $39.6K sold.

B. Riley Wealth Advisors first reported a position in AUTL in Q2 2023 and held it in 3 quarters. The position peaked at $52.4K in Q2 2023. 111 funds tracked by Wall St. Rank hold AUTL as of Q2 2024.

  • B. Riley Wealth Advisors reported no remaining Autolus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 17,000 Autolus Therapeutics shares in Q2 2024, an estimated $39.6K.
  • B. Riley Wealth Advisors first reported a position in Autolus Therapeutics in Q2 2023 and held it in 3 quarters.
  • B. Riley Wealth Advisors's Autolus Therapeutics position peaked at $52.4K in Q2 2023.
  • 111 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2024.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2024, filed 19 Aug 2024.